메뉴 건너뛰기




Volumn 13, Issue , 2013, Pages

The association of TP53 mutations with the resistance of colorectal carcinoma to the insulin-like growth factor-1 receptor inhibitor picropodophyllin

Author keywords

Apoptosis; Colorectal carcinoma; ERK; IGF 1R; IGF 1R inhibitor; TP53

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE; CASPASE 3; CASPASE 9; DNA FRAGMENT; DNA FRAGMENTATION FACTOR 45; MITOGEN ACTIVATED PROTEIN KINASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PICROPODOPHYLLIN; PROTEIN BAD; PROTEIN KINASE B; PROTEIN P53; SOMATOMEDIN C RECEPTOR; UNCLASSIFIED DRUG; X LINKED INHIBITOR OF APOPTOSIS;

EID: 84886732562     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-13-521     Document Type: Article
Times cited : (18)

References (49)
  • 1
    • 84857640868 scopus 로고    scopus 로고
    • The insulin and insulin-like growth factor receptor family in neoplasia: an update
    • Pollak M. The insulin and insulin-like growth factor receptor family in neoplasia: an update. Nat Rev Cancer 2012, 12(3):159-169.
    • (2012) Nat Rev Cancer , vol.12 , Issue.3 , pp. 159-169
    • Pollak, M.1
  • 2
    • 0034457923 scopus 로고    scopus 로고
    • Insulin-like growth factor I receptor signaling-overlapping or redundant pathways?
    • 10.1210/en.141.4.1287, 10746630
    • LeRoith D. Insulin-like growth factor I receptor signaling-overlapping or redundant pathways?. Endocrinology 2000, 141(4):1287-1288. 10.1210/en.141.4.1287, 10746630.
    • (2000) Endocrinology , vol.141 , Issue.4 , pp. 1287-1288
    • LeRoith, D.1
  • 3
    • 0032898811 scopus 로고    scopus 로고
    • Variation among cell types in the signaling pathways by which IGF-I stimulates specific cellular responses
    • Petley T, Graff K, Jiang W, Yang H, Florini J. Variation among cell types in the signaling pathways by which IGF-I stimulates specific cellular responses. Horm Metab Res 1999, 31(2-3):70-76.
    • (1999) Horm Metab Res , vol.31 , Issue.2-3 , pp. 70-76
    • Petley, T.1    Graff, K.2    Jiang, W.3    Yang, H.4    Florini, J.5
  • 4
    • 0030584088 scopus 로고    scopus 로고
    • Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L)
    • 10.1016/S0092-8674(00)81382-3, 8929531
    • Zha J, Harada H, Yang E, Jockel J, Korsmeyer SJ. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell 1996, 87(4):619-628. 10.1016/S0092-8674(00)81382-3, 8929531.
    • (1996) Cell , vol.87 , Issue.4 , pp. 619-628
    • Zha, J.1    Harada, H.2    Yang, E.3    Jockel, J.4    Korsmeyer, S.J.5
  • 5
    • 0034032010 scopus 로고    scopus 로고
    • Insulin-like growth factor-I protects colon cancer cells from death factor-induced apoptosis by potentiating tumor necrosis factor alpha-induced mitogen-activated protein kinase and nuclear factor kappaB signaling pathways
    • Remacle-Bonnet MM, Garrouste FL, Heller S, Andre F, Marvaldi JL, Pommier GJ. Insulin-like growth factor-I protects colon cancer cells from death factor-induced apoptosis by potentiating tumor necrosis factor alpha-induced mitogen-activated protein kinase and nuclear factor kappaB signaling pathways. Cancer Res 2000, 60(7):2007-2017.
    • (2000) Cancer Res , vol.60 , Issue.7 , pp. 2007-2017
    • Remacle-Bonnet, M.M.1    Garrouste, F.L.2    Heller, S.3    Andre, F.4    Marvaldi, J.L.5    Pommier, G.J.6
  • 6
    • 33846874575 scopus 로고    scopus 로고
    • The role of the IGF system in cancer growth and metastasis: overview and recent insights
    • Samani AA, Yakar S, LeRoith D, Brodt P. The role of the IGF system in cancer growth and metastasis: overview and recent insights. Endocr Rev 2007, 28(1):20-47.
    • (2007) Endocr Rev , vol.28 , Issue.1 , pp. 20-47
    • Samani, A.A.1    Yakar, S.2    LeRoith, D.3    Brodt, P.4
  • 7
    • 0035977198 scopus 로고    scopus 로고
    • IGF-1, IGF-2 and IGFBP-3 in prediagnostic serum: association with colorectal cancer in a cohort of Chinese men in Shanghai
    • 10.1054/bjoc.2001.2172, 2363974, 11742490
    • Probst-Hensch NM, Yuan JM, Stanczyk FZ, Gao YT, Ross RK, Yu MC. IGF-1, IGF-2 and IGFBP-3 in prediagnostic serum: association with colorectal cancer in a cohort of Chinese men in Shanghai. Br J Cancer 2001, 85(11):1695-1699. 10.1054/bjoc.2001.2172, 2363974, 11742490.
    • (2001) Br J Cancer , vol.85 , Issue.11 , pp. 1695-1699
    • Probst-Hensch, N.M.1    Yuan, J.M.2    Stanczyk, F.Z.3    Gao, Y.T.4    Ross, R.K.5    Yu, M.C.6
  • 8
    • 0036112482 scopus 로고    scopus 로고
    • Plasma insulin-like growth factor 1, insulin-like growth factor binding protein 3, and risk of colorectal cancer: a prospective study in northern Sweden
    • 10.1136/gut.50.5.642, 1773192, 11950809
    • Palmqvist R, Hallmans G, Rinaldi S, Biessy C, Stenling R, Riboli E, Kaaks R. Plasma insulin-like growth factor 1, insulin-like growth factor binding protein 3, and risk of colorectal cancer: a prospective study in northern Sweden. Gut 2002, 50(5):642-646. 10.1136/gut.50.5.642, 1773192, 11950809.
    • (2002) Gut , vol.50 , Issue.5 , pp. 642-646
    • Palmqvist, R.1    Hallmans, G.2    Rinaldi, S.3    Biessy, C.4    Stenling, R.5    Riboli, E.6    Kaaks, R.7
  • 9
    • 0033531765 scopus 로고    scopus 로고
    • Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3
    • 10.1093/jnci/91.7.620, 10203281
    • Ma J, Pollak MN, Giovannucci E, Chan JM, Tao Y, Hennekens CH, Stampfer MJ. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J Natl Cancer Inst 1999, 91(7):620-625. 10.1093/jnci/91.7.620, 10203281.
    • (1999) J Natl Cancer Inst , vol.91 , Issue.7 , pp. 620-625
    • Ma, J.1    Pollak, M.N.2    Giovannucci, E.3    Chan, J.M.4    Tao, Y.5    Hennekens, C.H.6    Stampfer, M.J.7
  • 11
    • 0022853272 scopus 로고
    • Enhanced levels of insulin-like growth factor messenger RNA in human colon carcinomas and liposarcomas
    • Tricoli JV, Rall LB, Karakousis CP, Herrera L, Petrelli NJ, Bell GI, Shows TB. Enhanced levels of insulin-like growth factor messenger RNA in human colon carcinomas and liposarcomas. Cancer Res 1986, 46(12 Pt 1):6169-6173.
    • (1986) Cancer Res , vol.46 , Issue.12 PART 1 , pp. 6169-6173
    • Tricoli, J.V.1    Rall, L.B.2    Karakousis, C.P.3    Herrera, L.4    Petrelli, N.J.5    Bell, G.I.6    Shows, T.B.7
  • 12
    • 0025005049 scopus 로고
    • Abnormal expression and structural modification of the insulin-like growth-factor-II gene in human colorectal tumors
    • 10.1002/ijc.2910460313, 1975564
    • Lambert S, Vivario J, Boniver J, Gol-Winkler R. Abnormal expression and structural modification of the insulin-like growth-factor-II gene in human colorectal tumors. Int J Cancer 1990, 46(3):405-410. 10.1002/ijc.2910460313, 1975564.
    • (1990) Int J Cancer , vol.46 , Issue.3 , pp. 405-410
    • Lambert, S.1    Vivario, J.2    Boniver, J.3    Gol-Winkler, R.4
  • 14
    • 0033044313 scopus 로고    scopus 로고
    • Expression of the insulin-like growth factors and their receptors in adenocarcinoma of the colon
    • 10.1136/gut.44.5.704, 1727486, 10205209
    • Freier S, Weiss O, Eran M, Flyvbjerg A, Dahan R, Nephesh I, Safra T, Shiloni E, Raz I. Expression of the insulin-like growth factors and their receptors in adenocarcinoma of the colon. Gut 1999, 44(5):704-708. 10.1136/gut.44.5.704, 1727486, 10205209.
    • (1999) Gut , vol.44 , Issue.5 , pp. 704-708
    • Freier, S.1    Weiss, O.2    Eran, M.3    Flyvbjerg, A.4    Dahan, R.5    Nephesh, I.6    Safra, T.7    Shiloni, E.8    Raz, I.9
  • 15
    • 0037110602 scopus 로고    scopus 로고
    • Overexpression of the insulin-like growth factor I receptor in human colon carcinomas
    • 10.1002/cncr.10945, 12412161
    • Weber MM, Fottner C, Liu SB, Jung MC, Engelhardt D, Baretton GB. Overexpression of the insulin-like growth factor I receptor in human colon carcinomas. Cancer 2002, 95(10):2086-2095. 10.1002/cncr.10945, 12412161.
    • (2002) Cancer , vol.95 , Issue.10 , pp. 2086-2095
    • Weber, M.M.1    Fottner, C.2    Liu, S.B.3    Jung, M.C.4    Engelhardt, D.5    Baretton, G.B.6
  • 16
    • 84881523535 scopus 로고    scopus 로고
    • Targeting the insulin-like growth factor-1 receptor in human cancer
    • 3605519, 23525758
    • Arcaro A. Targeting the insulin-like growth factor-1 receptor in human cancer. Front Pharmacol 2013, 4:30. 3605519, 23525758.
    • (2013) Front Pharmacol , vol.4 , pp. 30
    • Arcaro, A.1
  • 17
    • 62749203737 scopus 로고    scopus 로고
    • Insulin-like growth factor 1 receptor targeted therapeutics: novel compounds and novel treatment strategies for cancer medicine
    • 10.2174/157489209787002515, 19149688
    • Hewish M, Chau I, Cunningham D. Insulin-like growth factor 1 receptor targeted therapeutics: novel compounds and novel treatment strategies for cancer medicine. Recent Pat Anticancer Drug Discov 2009, 4(1):54-72. 10.2174/157489209787002515, 19149688.
    • (2009) Recent Pat Anticancer Drug Discov , vol.4 , Issue.1 , pp. 54-72
    • Hewish, M.1    Chau, I.2    Cunningham, D.3
  • 18
    • 83455236504 scopus 로고    scopus 로고
    • Insulin-like growth factor: current concepts and new developments in cancer therapy
    • 10.2174/157489212798357930, 3724215, 21875414
    • King ER, Wong KK. Insulin-like growth factor: current concepts and new developments in cancer therapy. Recent Pat Anticancer Drug Discov 2012, 7(1):14-30. 10.2174/157489212798357930, 3724215, 21875414.
    • (2012) Recent Pat Anticancer Drug Discov , vol.7 , Issue.1 , pp. 14-30
    • King, E.R.1    Wong, K.K.2
  • 19
    • 77956571417 scopus 로고    scopus 로고
    • Targeting insulin-like growth factor signaling: rational combination strategies
    • 10.1158/1535-7163.MCT-10-0719, 20807783
    • Olmos D, Basu B, de Bono JS. Targeting insulin-like growth factor signaling: rational combination strategies. Mol Cancer Ther 2010, 9(9):2447-2449. 10.1158/1535-7163.MCT-10-0719, 20807783.
    • (2010) Mol Cancer Ther , vol.9 , Issue.9 , pp. 2447-2449
    • Olmos, D.1    Basu, B.2    de Bono, J.S.3
  • 20
    • 69449097339 scopus 로고    scopus 로고
    • Emerging role of insulin-like growth factor receptor inhibitors in oncology: early clinical trial results and future directions
    • 10.1038/onc.2009.172, 19581933
    • Gualberto A, Pollak M. Emerging role of insulin-like growth factor receptor inhibitors in oncology: early clinical trial results and future directions. Oncogene 2009, 28(34):3009-3021. 10.1038/onc.2009.172, 19581933.
    • (2009) Oncogene , vol.28 , Issue.34 , pp. 3009-3021
    • Gualberto, A.1    Pollak, M.2
  • 21
    • 77957962308 scopus 로고    scopus 로고
    • Randomized, phase II study of the insulin-like growth factor-1 receptor inhibitor IMC-A12, with or without cetuximab, in patients with cetuximab- or panitumumab-refractory metastatic colorectal cancer
    • 10.1200/JCO.2010.30.4154, 3296668, 20713879
    • Reidy DL, Vakiani E, Fakih MG, Saif MW, Hecht JR, Goodman-Davis N, Hollywood E, Shia J, Schwartz J, Chandrawansa K, et al. Randomized, phase II study of the insulin-like growth factor-1 receptor inhibitor IMC-A12, with or without cetuximab, in patients with cetuximab- or panitumumab-refractory metastatic colorectal cancer. J Clin Oncol 2010, 28(27):4240-4246. 10.1200/JCO.2010.30.4154, 3296668, 20713879.
    • (2010) J Clin Oncol , vol.28 , Issue.27 , pp. 4240-4246
    • Reidy, D.L.1    Vakiani, E.2    Fakih, M.G.3    Saif, M.W.4    Hecht, J.R.5    Goodman-Davis, N.6    Hollywood, E.7    Shia, J.8    Schwartz, J.9    Chandrawansa, K.10
  • 22
    • 0035185571 scopus 로고    scopus 로고
    • Structure and autoregulation of the insulin-like growth factor 1 receptor kinase
    • 10.1038/nsb721, 11694888
    • Favelyukis S, Till JH, Hubbard SR, Miller WT. Structure and autoregulation of the insulin-like growth factor 1 receptor kinase. Nat Struct Biol 2001, 8(12):1058-1063. 10.1038/nsb721, 11694888.
    • (2001) Nat Struct Biol , vol.8 , Issue.12 , pp. 1058-1063
    • Favelyukis, S.1    Till, J.H.2    Hubbard, S.R.3    Miller, W.T.4
  • 23
    • 0034793734 scopus 로고    scopus 로고
    • Crystal structure of bisphosphorylated IGF-1 receptor kinase: insight into domain movements upon kinase activation
    • 10.1016/S0969-2126(01)00655-4, 11591350
    • Pautsch A, Zoephel A, Ahorn H, Spevak W, Hauptmann R, Nar H. Crystal structure of bisphosphorylated IGF-1 receptor kinase: insight into domain movements upon kinase activation. Structure 2001, 9(10):955-965. 10.1016/S0969-2126(01)00655-4, 11591350.
    • (2001) Structure , vol.9 , Issue.10 , pp. 955-965
    • Pautsch, A.1    Zoephel, A.2    Ahorn, H.3    Spevak, W.4    Hauptmann, R.5    Nar, H.6
  • 24
    • 12144290914 scopus 로고    scopus 로고
    • Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumors
    • 10.1016/S1535-6108(04)00050-9, 15050914
    • Mitsiades CS, Mitsiades NS, McMullan CJ, Poulaki V, Shringarpure R, Akiyama M, Hideshima T, Chauhan D, Joseph M, Libermann TA, et al. Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumors. Cancer Cell 2004, 5(3):221-230. 10.1016/S1535-6108(04)00050-9, 15050914.
    • (2004) Cancer Cell , vol.5 , Issue.3 , pp. 221-230
    • Mitsiades, C.S.1    Mitsiades, N.S.2    McMullan, C.J.3    Poulaki, V.4    Shringarpure, R.5    Akiyama, M.6    Hideshima, T.7    Chauhan, D.8    Joseph, M.9    Libermann, T.A.10
  • 25
    • 1642494838 scopus 로고    scopus 로고
    • Cyclolignans as inhibitors of the insulin-like growth factor-1 receptor and malignant cell growth
    • 10.1158/0008-5472.CAN-03-2522, 14729630
    • Girnita A, Girnita L, del Prete F, Bartolazzi A, Larsson O, Axelson M. Cyclolignans as inhibitors of the insulin-like growth factor-1 receptor and malignant cell growth. Cancer Res 2004, 64(1):236-242. 10.1158/0008-5472.CAN-03-2522, 14729630.
    • (2004) Cancer Res , vol.64 , Issue.1 , pp. 236-242
    • Girnita, A.1    Girnita, L.2    del Prete, F.3    Bartolazzi, A.4    Larsson, O.5    Axelson, M.6
  • 26
    • 7644223079 scopus 로고    scopus 로고
    • The cyclolignan PPP induces activation loop-specific inhibition of tyrosine phosphorylation of the insulin-like growth factor-1 receptor. Link to the phosphatidyl inositol-3 kinase/Akt apoptotic pathway
    • 10.1038/sj.onc.1208065, 15334055
    • Vasilcanu D, Girnita A, Girnita L, Vasilcanu R, Axelson M, Larsson O. The cyclolignan PPP induces activation loop-specific inhibition of tyrosine phosphorylation of the insulin-like growth factor-1 receptor. Link to the phosphatidyl inositol-3 kinase/Akt apoptotic pathway. Oncogene 2004, 23(47):7854-7862. 10.1038/sj.onc.1208065, 15334055.
    • (2004) Oncogene , vol.23 , Issue.47 , pp. 7854-7862
    • Vasilcanu, D.1    Girnita, A.2    Girnita, L.3    Vasilcanu, R.4    Axelson, M.5    Larsson, O.6
  • 27
    • 30444448398 scopus 로고    scopus 로고
    • IGF-1 receptor tyrosine kinase inhibition by the cyclolignan PPP induces G2/M-phase accumulation and apoptosis in multiple myeloma cells
    • 10.1182/blood-2005-01-0306, 16166596
    • Stromberg T, Ekman S, Girnita L, Dimberg LY, Larsson O, Axelson M, Lennartsson J, Hellman U, Carlson K, Osterborg A, et al. IGF-1 receptor tyrosine kinase inhibition by the cyclolignan PPP induces G2/M-phase accumulation and apoptosis in multiple myeloma cells. Blood 2006, 107(2):669-678. 10.1182/blood-2005-01-0306, 16166596.
    • (2006) Blood , vol.107 , Issue.2 , pp. 669-678
    • Stromberg, T.1    Ekman, S.2    Girnita, L.3    Dimberg, L.Y.4    Larsson, O.5    Axelson, M.6    Lennartsson, J.7    Hellman, U.8    Carlson, K.9    Osterborg, A.10
  • 28
    • 34548699650 scopus 로고    scopus 로고
    • Targeting the IGF-1R using picropodophyllin in the therapeutical 5T2MM mouse model of multiple myeloma: beneficial effects on tumor growth, angiogenesis, bone disease and survival
    • 10.1002/ijc.22845, 17546599
    • Menu E, Jernberg-Wiklund H, De Raeve H, De Leenheer E, Coulton L, Gallagher O, Van Valckenborgh E, Larsson O, Axelson M, Nilsson K, et al. Targeting the IGF-1R using picropodophyllin in the therapeutical 5T2MM mouse model of multiple myeloma: beneficial effects on tumor growth, angiogenesis, bone disease and survival. Int J Cancer 2007, 121(8):1857-1861. 10.1002/ijc.22845, 17546599.
    • (2007) Int J Cancer , vol.121 , Issue.8 , pp. 1857-1861
    • Menu, E.1    Jernberg-Wiklund, H.2    De Raeve, H.3    De Leenheer, E.4    Coulton, L.5    Gallagher, O.6    Van Valckenborgh, E.7    Larsson, O.8    Axelson, M.9    Nilsson, K.10
  • 29
    • 30444446821 scopus 로고    scopus 로고
    • Inhibiting the IGF-1 receptor tyrosine kinase with the cyclolignan PPP: an in vitro and in vivo study in the 5T33MM mouse model
    • 10.1182/blood-2005-01-0293, 16046527
    • Menu E, Jernberg-Wiklund H, Stromberg T, De Raeve H, Girnita L, Larsson O, Axelson M, Asosingh K, Nilsson K, Van Camp B, et al. Inhibiting the IGF-1 receptor tyrosine kinase with the cyclolignan PPP: an in vitro and in vivo study in the 5T33MM mouse model. Blood 2006, 107(2):655-660. 10.1182/blood-2005-01-0293, 16046527.
    • (2006) Blood , vol.107 , Issue.2 , pp. 655-660
    • Menu, E.1    Jernberg-Wiklund, H.2    Stromberg, T.3    De Raeve, H.4    Girnita, L.5    Larsson, O.6    Axelson, M.7    Asosingh, K.8    Nilsson, K.9    Van Camp, B.10
  • 30
    • 75749094341 scopus 로고    scopus 로고
    • Targeting the insulin-like growth factor-1 receptor by picropodophyllin as a treatment option for glioblastoma
    • 10.1093/neuonc/nop008, 2940558, 20150364
    • Yin S, Girnita A, Stromberg T, Khan Z, Andersson S, Zheng H, Ericsson C, Axelson M, Nister M, Larsson O, et al. Targeting the insulin-like growth factor-1 receptor by picropodophyllin as a treatment option for glioblastoma. Neuro Oncol 2010, 12(1):19-27. 10.1093/neuonc/nop008, 2940558, 20150364.
    • (2010) Neuro Oncol , vol.12 , Issue.1 , pp. 19-27
    • Yin, S.1    Girnita, A.2    Stromberg, T.3    Khan, Z.4    Andersson, S.5    Zheng, H.6    Ericsson, C.7    Axelson, M.8    Nister, M.9    Larsson, O.10
  • 31
    • 84863922124 scopus 로고    scopus 로고
    • Comprehensive molecular characterization of human colon and rectal cancer
    • 10.1038/nature11252, 3401966, 22810696
    • Muzny DM, Bainbridge MN, Chang K, et al. Comprehensive molecular characterization of human colon and rectal cancer. Nature 2012, 487(7407):330-337. 10.1038/nature11252, 3401966, 22810696.
    • (2012) Nature , vol.487 , Issue.7407 , pp. 330-337
    • Muzny, D.M.1    Bainbridge, M.N.2    Chang, K.3
  • 32
    • 84861325324 scopus 로고    scopus 로고
    • A20 ubiquitin ligase-mediated polyubiquitination of RIP1 inhibits caspase-8 cleavage and TRAIL-induced apoptosis in glioblastoma
    • 10.1158/2159-8290.CD-11-0172, 3354650, 22585859
    • Bellail AC, Olson JJ, Yang X, Chen ZJ, Hao C. A20 ubiquitin ligase-mediated polyubiquitination of RIP1 inhibits caspase-8 cleavage and TRAIL-induced apoptosis in glioblastoma. Cancer Discov 2012, 2(2):140-155. 10.1158/2159-8290.CD-11-0172, 3354650, 22585859.
    • (2012) Cancer Discov , vol.2 , Issue.2 , pp. 140-155
    • Bellail, A.C.1    Olson, J.J.2    Yang, X.3    Chen, Z.J.4    Hao, C.5
  • 33
    • 32244446245 scopus 로고    scopus 로고
    • Analysis of P53 mutations and their expression in 56 colorectal cancer cell lines
    • 10.1073/pnas.0510146103, 1327731, 16418264
    • Liu Y, Bodmer WF. Analysis of P53 mutations and their expression in 56 colorectal cancer cell lines. Proc Natl Acad Sci USA 2006, 103(4):976-981. 10.1073/pnas.0510146103, 1327731, 16418264.
    • (2006) Proc Natl Acad Sci USA , vol.103 , Issue.4 , pp. 976-981
    • Liu, Y.1    Bodmer, W.F.2
  • 35
    • 40449095393 scopus 로고    scopus 로고
    • Picropodophyllin induces downregulation of the insulin-like growth factor 1 receptor: potential mechanistic involvement of Mdm2 and beta-arrestin1
    • 10.1038/sj.onc.1210797, 17828296
    • Vasilcanu R, Vasilcanu D, Rosengren L, Natalishvili N, Sehat B, Yin S, Girnita A, Axelson M, Girnita L, Larsson O. Picropodophyllin induces downregulation of the insulin-like growth factor 1 receptor: potential mechanistic involvement of Mdm2 and beta-arrestin1. Oncogene 2008, 27(11):1629-1638. 10.1038/sj.onc.1210797, 17828296.
    • (2008) Oncogene , vol.27 , Issue.11 , pp. 1629-1638
    • Vasilcanu, R.1    Vasilcanu, D.2    Rosengren, L.3    Natalishvili, N.4    Sehat, B.5    Yin, S.6    Girnita, A.7    Axelson, M.8    Girnita, L.9    Larsson, O.10
  • 36
    • 0037816235 scopus 로고    scopus 로고
    • Mdm2-dependent ubiquitination and degradation of the insulin-like growth factor 1 receptor
    • 10.1073/pnas.1431613100, 166214, 12821780
    • Girnita L, Girnita A, Larsson O. Mdm2-dependent ubiquitination and degradation of the insulin-like growth factor 1 receptor. Proc Natl Acad Sci USA 2003, 100(14):8247-8252. 10.1073/pnas.1431613100, 166214, 12821780.
    • (2003) Proc Natl Acad Sci USA , vol.100 , Issue.14 , pp. 8247-8252
    • Girnita, L.1    Girnita, A.2    Larsson, O.3
  • 37
    • 40849131149 scopus 로고    scopus 로고
    • Insulin-like growth factor type-I receptor-dependent phosphorylation of extracellular signal-regulated kinase 1/2 but not Akt (protein kinase B) can be induced by picropodophyllin
    • Vasilcanu R, Vasilcanu D, Sehat B, Yin S, Girnita A, Axelson M, Girnita L. Insulin-like growth factor type-I receptor-dependent phosphorylation of extracellular signal-regulated kinase 1/2 but not Akt (protein kinase B) can be induced by picropodophyllin. Mol Pharmacol 2008, 73(3):930-939.
    • (2008) Mol Pharmacol , vol.73 , Issue.3 , pp. 930-939
    • Vasilcanu, R.1    Vasilcanu, D.2    Sehat, B.3    Yin, S.4    Girnita, A.5    Axelson, M.6    Girnita, L.7
  • 38
    • 84874417600 scopus 로고    scopus 로고
    • Beta-arrestin-biased agonism as the central mechanism of action for insulin-like growth factor 1 receptor-targeting antibodies in Ewing's sarcoma
    • 10.1073/pnas.1216348110, 3528604, 23188799
    • Zheng H, Shen H, Oprea I, Worrall C, Stefanescu R, Girnita A, Girnita L. beta-arrestin-biased agonism as the central mechanism of action for insulin-like growth factor 1 receptor-targeting antibodies in Ewing's sarcoma. Proc Natl Acad Sci USA 2012, 109(50):20620-20625. 10.1073/pnas.1216348110, 3528604, 23188799.
    • (2012) Proc Natl Acad Sci USA , vol.109 , Issue.50 , pp. 20620-20625
    • Zheng, H.1    Shen, H.2    Oprea, I.3    Worrall, C.4    Stefanescu, R.5    Girnita, A.6    Girnita, L.7
  • 39
    • 77955165505 scopus 로고    scopus 로고
    • DR5-mediated DISC controls caspase-8 cleavage and initiation of apoptosis in human glioblastomas
    • 10.1111/j.1582-4934.2009.00777.x, 2891654, 19432816
    • Bellail AC, Tse MC, Song JH, Phuphanich S, Olson JJ, Sun SY, Hao C. DR5-mediated DISC controls caspase-8 cleavage and initiation of apoptosis in human glioblastomas. J Cell Mol Med 2010, 14(6A):1303-1317. 10.1111/j.1582-4934.2009.00777.x, 2891654, 19432816.
    • (2010) J Cell Mol Med , vol.14 , Issue.6 A , pp. 1303-1317
    • Bellail, A.C.1    Tse, M.C.2    Song, J.H.3    Phuphanich, S.4    Olson, J.J.5    Sun, S.Y.6    Hao, C.7
  • 40
    • 0034616945 scopus 로고    scopus 로고
    • Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition
    • 10.1016/S0092-8674(00)00008-8, 10929711
    • Du C, Fang M, Li Y, Li L, Wang X. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 2000, 102(1):33-42. 10.1016/S0092-8674(00)00008-8, 10929711.
    • (2000) Cell , vol.102 , Issue.1 , pp. 33-42
    • Du, C.1    Fang, M.2    Li, Y.3    Li, L.4    Wang, X.5
  • 41
    • 0034616942 scopus 로고    scopus 로고
    • Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins
    • 10.1016/S0092-8674(00)00009-X, 10929712
    • Verhagen AM, Ekert PG, Pakusch M, Silke J, Connolly LM, Reid GE, Moritz RL, Simpson RJ, Vaux DL. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell 2000, 102(1):43-53. 10.1016/S0092-8674(00)00009-X, 10929712.
    • (2000) Cell , vol.102 , Issue.1 , pp. 43-53
    • Verhagen, A.M.1    Ekert, P.G.2    Pakusch, M.3    Silke, J.4    Connolly, L.M.5    Reid, G.E.6    Moritz, R.L.7    Simpson, R.J.8    Vaux, D.L.9
  • 42
    • 84855792427 scopus 로고    scopus 로고
    • Cancer statistics, 2012
    • 10.3322/caac.20138, 22237781
    • Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012, 62(1):10-29. 10.3322/caac.20138, 22237781.
    • (2012) CA Cancer J Clin , vol.62 , Issue.1 , pp. 10-29
    • Siegel, R.1    Naishadham, D.2    Jemal, A.3
  • 44
    • 0032885494 scopus 로고    scopus 로고
    • Expression of insulin-like growth factor-1 receptor in human colorectal cancer
    • 10.1016/S0046-8177(99)90027-8, 10534157
    • Hakam A, Yeatman TJ, Lu L, Mora L, Marcet G, Nicosia SV, Karl RC, Coppola D. Expression of insulin-like growth factor-1 receptor in human colorectal cancer. Hum Pathol 1999, 30(10):1128-1133. 10.1016/S0046-8177(99)90027-8, 10534157.
    • (1999) Hum Pathol , vol.30 , Issue.10 , pp. 1128-1133
    • Hakam, A.1    Yeatman, T.J.2    Lu, L.3    Mora, L.4    Marcet, G.5    Nicosia, S.V.6    Karl, R.C.7    Coppola, D.8
  • 45
    • 34548058890 scopus 로고    scopus 로고
    • A novel, potent, and selective insulin-like growth factor-I receptor kinase inhibitor blocks insulin-like growth factor-I receptor signaling in vitro and inhibits insulin-like growth factor-I receptor dependent tumor growth in vivo
    • 10.1158/1535-7163.MCT-07-0070, 17671083
    • Ji QS, Mulvihill MJ, Rosenfeld-Franklin M, Cooke A, Feng L, Mak G, O'Connor M, Yao Y, Pirritt C, Buck E, et al. A novel, potent, and selective insulin-like growth factor-I receptor kinase inhibitor blocks insulin-like growth factor-I receptor signaling in vitro and inhibits insulin-like growth factor-I receptor dependent tumor growth in vivo. Mol Cancer Ther 2007, 6(8):2158-2167. 10.1158/1535-7163.MCT-07-0070, 17671083.
    • (2007) Mol Cancer Ther , vol.6 , Issue.8 , pp. 2158-2167
    • Ji, Q.S.1    Mulvihill, M.J.2    Rosenfeld-Franklin, M.3    Cooke, A.4    Feng, L.5    Mak, G.6    O'Connor, M.7    Yao, Y.8    Pirritt, C.9    Buck, E.10
  • 46
    • 78349254271 scopus 로고    scopus 로고
    • The insulin-like growth factor I receptor/insulin receptor tyrosine kinase inhibitor PQIP exhibits enhanced antitumor effects in combination with chemotherapy against colorectal cancer models
    • 10.1158/1078-0432.CCR-10-2054, 3119523, 20943761
    • Flanigan SA, Pitts TM, Eckhardt SG, Tentler JJ, Tan AC, Thorburn A, Leong S. The insulin-like growth factor I receptor/insulin receptor tyrosine kinase inhibitor PQIP exhibits enhanced antitumor effects in combination with chemotherapy against colorectal cancer models. Clin Cancer Res 2010, 16(22):5436-5446. 10.1158/1078-0432.CCR-10-2054, 3119523, 20943761.
    • (2010) Clin Cancer Res , vol.16 , Issue.22 , pp. 5436-5446
    • Flanigan, S.A.1    Pitts, T.M.2    Eckhardt, S.G.3    Tentler, J.J.4    Tan, A.C.5    Thorburn, A.6    Leong, S.7
  • 47
    • 66449091211 scopus 로고    scopus 로고
    • Dual silencing of insulin-like growth factor-I receptor and epidermal growth factor receptor in colorectal cancer cells is associated with decreased proliferation and enhanced apoptosis
    • 10.1158/1535-7163.MCT-09-0058, 19372555
    • Kaulfuss S, Burfeind P, Gaedcke J, Scharf JG. Dual silencing of insulin-like growth factor-I receptor and epidermal growth factor receptor in colorectal cancer cells is associated with decreased proliferation and enhanced apoptosis. Mol Cancer Ther 2009, 8(4):821-833. 10.1158/1535-7163.MCT-09-0058, 19372555.
    • (2009) Mol Cancer Ther , vol.8 , Issue.4 , pp. 821-833
    • Kaulfuss, S.1    Burfeind, P.2    Gaedcke, J.3    Scharf, J.G.4
  • 48
    • 54249155585 scopus 로고    scopus 로고
    • Heterogeneity of receptor function in colon carcinoma cells determined by cross-talk between type I insulin-like growth factor receptor and epidermal growth factor receptor
    • 10.1158/0008-5472.CAN-08-0280, 18829558
    • Hu YP, Patil SB, Panasiewicz M, Li W, Hauser J, Humphrey LE, Brattain MG. Heterogeneity of receptor function in colon carcinoma cells determined by cross-talk between type I insulin-like growth factor receptor and epidermal growth factor receptor. Cancer Res 2008, 68(19):8004-8013. 10.1158/0008-5472.CAN-08-0280, 18829558.
    • (2008) Cancer Res , vol.68 , Issue.19 , pp. 8004-8013
    • Hu, Y.P.1    Patil, S.B.2    Panasiewicz, M.3    Li, W.4    Hauser, J.5    Humphrey, L.E.6    Brattain, M.G.7
  • 49
    • 1542353401 scopus 로고    scopus 로고
    • Control of apoptosis by p53
    • 10.1038/sj.onc.1207116, 14663481
    • Fridman JS, Lowe SW. Control of apoptosis by p53. Oncogene 2003, 22(56):9030-9040. 10.1038/sj.onc.1207116, 14663481.
    • (2003) Oncogene , vol.22 , Issue.56 , pp. 9030-9040
    • Fridman, J.S.1    Lowe, S.W.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.